2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

What Industry-Specific Factors Are Fueling the Growth of theLeqvio Market?

The growing prevalence of cardiovascular diseases is expected to boost the growth of the Leqvio market. Cardiovascular diseases, which impact the heart and blood vessels, lead to conditions like heart attacks, strokes, and high blood pressure. Key contributing factors include unhealthy diet, physical inactivity, excessive alcohol consumption, diabetes, and age. Leqvio works by blocking the PCSK9 protein, which helps the liver clear LDL cholesterol, thereby reducing the risk of heart attacks, strokes, and other cardiovascular events. For example, in September 2024, the British Heart Foundation reported that about 7.6 million people in the UK are affected by heart and circulatory diseases, with approximately 4 million males and 3.6 million females living with these conditions. These diseases account for about 27% of all deaths in the UK, translating to over 170,000 deaths annually. This increasing prevalence is driving the growth of the Leqvio market.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20143&type=smp

#What is the Projected CAGR for the Leqvio Market Size from 2025 to 2034?

The leqvio market size has XX (HCAGR) in recent years. It is projected to increase from $XX million in 2024 to $XX million in 2025 at a CAGR of XX%. Past growth was influenced by RNA-based drug development funding, spending on cholesterol medications, R&D investments, increased healthcare awareness, and demand for targeted treatments.

The leqvio market size is expected to reach $XX million in 2029 at a compound annual growth rate (CAGR) of XX%. The growth is driven by the rising global prevalence of cardiovascular diseases, awareness of PCSK9 inhibitors’ efficacy, increasing cholesterol levels, aging population, and the growth of biologic drugs. Trends include rising demand for hypercholesterolemia treatments, expanding indications, FDA approvals, and biopharmaceutical R&D advancements.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20143

What Key Market Trends and Innovations Are Shaping the Future of theLeqvio Industry?

The key trend in the Leqvio market is the development of long-acting injectable prescription medicine to improve adherence and outcomes in cholesterol management. In July 2023, Novartis received FDA approval for a label update allowing Leqvio (inclisiran) use at an earlier stage for patients with elevated LDL-C, offering up to 52% LDL-C reduction with two doses per year after initial treatment.

Which Companies Are Leading the Charge in Expanding theLeqvio Market Growth?

Major companies operating in the leqvio market include Novartis AG

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/leqvio-global-market-report

How is the Global Leqvio Market Segemented?

The leqvio market covered in this report is segmented –

1) By Formulation: Injectable Formulation (Subcutaneous), Pre-Filled Syringes Or Auto-Injectors

2) By Indication: Treatment Of Hyperlipidemia, Management Of Atherosclerotic Cardiovascular Disease (ASCVD), Treatment Of Familial Hypercholesterolemia

3) By Patient Demographics: Adult Patients, Geriatric Patients, Patients with Comorbid Conditions

4) By Distribution Channel: Direct Sales, Wholesalers and Distributors, Retail Pharmacies, Online Pharmacies

5) By End-User: Hospitals, Cardiovascular Clinics, Specialty Pharmacies, Home Healthcare Providers

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=20143&type=smp

Which Geographics are Influencing the Growth of the Leqvio Market?

North America was the largest region in the leqvio market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the leqvio market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Browse Through More Reports Similar to the Global Leqvio Market 2025, By The Business Research Company:

Cholesterol Test Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cholesterol-test-global-market-report

Body Fat Reduction Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/body-fat-reduction-global-market-report

Fatty Liver Treatment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/fatty-liver-treatment-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: